| abstract |
PROBLEM TO BE SOLVED: To provide a glucagon-like peptide and its use for treatment. Vertebrate GLP-2 and vertebrate GLP-2 in that an amino acid having an addition, deletion, substitution or N-terminal or C-terminal amino acid blocking group of at least one amino acid is incorporated. A GLP-2 peptide selected from different enterotrophic vertebrate GLP-2 analogs, and a pharmaceutically acceptable carrier, provided that the GLP-2 peptide is human GLP-2 A pharmaceutical composition wherein the carrier is not 0.9% saline per se. [Selection figure] None |